Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Daiichi Sankyo Company, Limited
  6. Company
    4568   JP3475350009

DAIICHI SANKYO COMPANY, LIMITED

(4568)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.

Number of employees : 16 033 people.
Sales per Business
20202021Delta
Prescription Drugs911 262.0092.8%892 923.0092.8% -2.01%
Health Care68 403.007%67 425.007% -1.43%
Other2 127.000.2%2 167.000.2% +1.88%
JPY in Million
Sales per region
20202021Delta
Japan607 712.0061.9%560 725.0058.3% -7.73%
North America183 081.0018.6%191 651.0019.9% +4.68%
Europe95 728.009.8%114 047.0011.8% +19.14%
Other95 271.009.7%96 091.0010% +0.86%
JPY in Million
Managers
Name Title Age Since
Sunao Manabe President, CEO & Representative Director 67 2019
Hiroyuki Okuzawa CFO, Director, Executive Officer & Head-Management 58 2021
Ken Takeshita Global Director-Research & Development - 2021
Noritaka Uji Independent Outside Director 72 2014
Tsuguya Fukui Independent Outside Director 70 2015
Kazuaki Kama Independent Outside Director 72 2019
Sawako Nohara Independent Outside Director 63 2019
Ryoji Nagasaka Managing Executive Officer & Head-Secretariat - 2016
Junichi Koga Senior Managing Executive Officer, Global Head-R&D - 2019
Satoru Kimura Representative Director & Senior Executive Officer 63 2021
Members of the board
Name Title Age Since
Sunao Manabe President, CEO & Representative Director 67 2019
Noritaka Uji Independent Outside Director 72 2014
Satoru Kimura Representative Director & Senior Executive Officer 63 2021
Masahiko Ohtsuki Director & Senior Executive Officer - 2020
Tsuguya Fukui Independent Outside Director 70 2015
Kazuaki Kama Independent Outside Director 72 2019
Sawako Nohara Independent Outside Director 63 2019
Shoji Hirashima Director & Senior Executive Officer - 2020
Hiroyuki Okuzawa CFO, Director, Executive Officer & Head-Management 58 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0.01 1,947,034,029 1,899,748,309 97.6% 30,606,239 1.6% 97.6%
Shareholders
NameEquities%
Capital Research & Management Co. (World Investors) 122,207,450 6.28%
Nippon Life Insurance Co. 107,328,000 5.51%
Nomura Asset Management Co., Ltd. 101,045,800 5.19%
Sumitomo Mitsui Trust Asset Management Co., Ltd. 68,223,600 3.50%
Capital Research & Management Co. (Global Investors) 55,040,900 2.83%
The Vanguard Group, Inc. 46,701,266 2.40%
Mizuho Bank Pension Fund 43,208,000 2.22%
Nikko Asset Management Co., Ltd. 41,392,500 2.13%
Daiwa Asset Management Co. Ltd. 40,112,287 2.06%
Wellington Management Co. LLP 36,673,656 1.88%
Holdings
NameEquities%Valuation
THE SHIZUOKA BANK, LTD. (8355) 9,343,000 1.57% 73,308,448 USD
ALFRESA HOLDINGS CORPORATION (2784) 3,202,144 1.36% 50,745,785 USD
COCOKARA FINE INC. (3098) 605,000 1.93% 47,690,698 USD
MEDIPAL HOLDINGS CORPORATION (7459) 2,184,007 0.89% 41,807,463 USD
SUZUKEN CO., LTD. (9987) 952,598 0.92% 28,354,232 USD
TORAY INDUSTRIES, INC. (3402) 3,339,000 0.20% 22,545,696 USD
AIN HOLDINGS INC. (9627) 114,000 0.32% 7,709,994 USD
HOKUYAKU TAKEYAMA HOLDINGS,INC. (3055) 438,500 1.80% 2,873,841 USD
THE IYO BANK, LTD. (8385) 470,000 0.15% 2,519,844 USD
SUMITOMO MITSUI TRUST HOLDINGS, INC. (8309) 22,485 0.0060% 736,401 USD
Markets and indexes
- First Section
- Nikkei 225 / Stoxx Asia Pacific 50, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  4568:JP
- Reuters Code :  4568.T
- Datastream Code :  
Company contact information
Daiichi Sankyo Co., Ltd.
Daiichi Sankyo Building A/B 3-5-1 Nihonbashi-Honcho
JP-103-8426 Chuo-ku, Tokyo

Phone : +81 3 6225 1111
Fax :
web site : https://www.daiichisankyo.com/
Brand Portfolio
In partnership withAllbrands.markets
More brands of Daiichi Sankyo Company, Limited
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
DAIICHI SANKYO COMPANY, LIMITED-20.66%48 910
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.20.81%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY36.28%208 604
ABBVIE INC.0.54%190 378
NOVARTIS AG-7.42%186 081
MERCK & CO., INC.-12.37%181 449
ASTRAZENECA PLC10.09%171 794
BRISTOL-MYERS SQUIBB COMPANY-1.16%136 238
AMGEN INC.-4.58%124 575
SANOFI3.62%120 158
GLAXOSMITHKLINE PLC3.44%95 560
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-23.73%62 799
TAKEDA PHARMACEUTICAL COMPANY LIMITED1.54%54 566
BAYER AG-6.12%52 137
JIANGSU HENGRUI MEDICINE CO., LTD.-49.45%46 272
ASTELLAS PHARMA INC.18.51%31 855
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY49.98%24 783